MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction-Reference-Cited by-同舟云学术

MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction

Published:2024-02 Issue: Volume:69 Page:102987
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Luo Xing,Wang Yuehong,Zhu Xinxin,Chen Yuwu,Xu Biyi,Bai Xiaoxuan,Weng Xiuzhu,Xu Jinmei,Tao Yangyang,Yang Dan,Du Jie,Lv Ying,Zhang Shan,Hu Sining,Li Ji,Jia Haibo^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference83 articles.

1. Injectable liposomal docosahexaenoic acid alleviates atherosclerosis progression and enhances plaque stability;Chong;J. Contr. Release : Offi. J. Controlled Release Soc.,2023

2. Macrophage phenotype and function in different stages of atherosclerosis;Tabas;Circ. Res.,2016

3. Macrophages in the pathogenesis of atherosclerosis;Moore;Cell,2011

4. GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis;Wei;Nat. Commun.,2023

5. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines;Gao;Nat. Commun.,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Swimming training attenuates doxorubicin induced cardiomyopathy by targeting the mir-17-3p/KEAP1/NRF2 axis;Biochemical and Biophysical Research Communications;2024-12

2. The complex interplay between ferroptosis and atherosclerosis;Biomedicine & Pharmacotherapy;2024-09

3. Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis;International Immunopharmacology;2024-09

4. Nrf2-mediated ferroptosis inhibition: a novel approach for managing inflammatory diseases;Inflammopharmacology;2024-08-10

5. Ferroptosis in ulcerative colitis: Potential mechanisms and promising therapeutic targets;Biomedicine & Pharmacotherapy;2024-06